|
Information For:
|
Tamsulosin Hydrochloride Capsules: Notice of Intent to ReviseDate Posted: April 8, 2009 In accordance with section 9.05(c) of the Rules and Procedures of the 2005-2010 Council of Experts, the Biopharmaceutics Expert Committee intends to add a new Dissolution test to the Tamsulosin Hydrochloride Capsules Monograph to reflect the approved marketed products. It is anticipated that the proposed revisions will be published as a Revision Bulletin pursuant to section 9.02(d) of the Rules and Procedures. Should you have questions, please contact Margareth Marques, Ph.D. (301-816-8106 or ). What's NewChanges to the Dissolution Performance Verification Test (11/20/09) PF 35(6) Errata (10/30/09) New official Text for October: 15 Revisions Bulletins (10/30/09) Pending Standards for the month of October (10/30/09) PF 35(6), November-December 2009: Highlights and Stimuli Articles (10/23/09) Admission Criteria and Safety Classification for Dietary Supplements Guideline (10/22/09) Elemental Impurities Hot Topics information updated (10/13/09) General Chapter <1151> Pharmaceutical Dosage Forms (10/06/09) Heparin Hot Topics information updated (10/02/09)
Related Resources |
||||||||||||||||||||||||||||
Copyright © 2009 The United States Pharmacopeial Convention
|
|||||||||||||||||||||||||||||